asked have questions. a you Well, of quite number
is it been tried or that that. and For one, fact your is with couple I as we have retire twice unsuccessful counting to in semi-retire right, have
been who X sitting our Hoffman has employees As far as most we company employees and X years. go, been has XX as X but is Dr. COO. employees also me. since Joseph are years, have as mostly CFO, XX been of with us has years years. years the with with for us with probably who over Joseph He us with down for
very been with is we have myself, employees, who good So, have been CEO. but absolutely dreadful replacing very, we as
certainly correct you are are – correct So, you there.
the have move will seen. I that in not am FDA it’s what surprised since are are being the as spot, and we as did at granted, difference all make far as that been as stock it we certainly really As declining with you are events and the where a significant
XXX,XXX looking shares saw shareholders of last above a organic year. number which don’t shares quite that that We volume. the XX,XXX with we positions about we and our shareholders noble we get at XX,XXX we have any had in and in funds increased have of shareholders they our list, We over fact movement see recently have shares have
am looking what is the So our is we are I moment, the which what moment all at basically the Epidural. at for putting into of efforts
we have since people capital, did the time to use And have approval we ammunition we on on within on when bring felt information that the we study, commercially to we delivery can we the people come is having in bring these it until a not people as of for are drug hire wait published major with or to as it which month We major very period were distributors. X close in that Epidural a FDA journal. to instrument manage study
So, that. waited we for
So, not, very we not this. because we then the we certainly very shareholders we dilute try which things little certain balance is there were that to are we if capitalized, and really only well raised needed, when to we try
lot delayed, of that. a things of So, are because
We the of that that make are I delaying Epidural and with instrument to mentioned arrangements forth because into cosmetic of now Intra-Articular earlier. our one bring we work our the are instrument, to with the the all efforts putting actually
as validate mentioned think – and stocks the far to when to go a greater deal company. as be personally strategy people as was will that I I that the I done So, major expertise that I event for first do in earlier, speak with have that
forward. certain well I do think extraordinarily will going that markets we see
here very company extraordinarily in doing They Sinopharm them. working have They country this Sinopharm our to over in and XX are to market $X with handpiece China. the of is China the divisions largest we here billion in here China as who are distribution the medical in ran years. subsidiary fortunate are China. we trying someone sales see are capture well We with
be can stock question, drivers increase a in disposable to, So, where while forward. agreement one I building strategic hand those the we sales or the we before. of the STA at position answer the Does your John? trying our that to have the sales a And business dental going Epidural licensing same events time sale mentioned joint or the think up I will venture are and on business that
